Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 134,553,130
- Total 13F shares
- 7,221,932
- Share change
- -769,447
- Total reported value
- $61,486,225
- Price per share
- $8.57
- Number of holders
- 42
- Value change
- -$7,070,486
- Number of buys
- 18
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 690469101:
Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
1.3%
|
1,814,847
|
$18,254,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.83%
|
1,121,085
|
$11,759,000 | — | 30 Jun 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.48%
|
650,074
|
$6,739,000 | — | 30 Jun 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.4%
|
535,824
|
$5,229,000 | — | 30 Jun 2017 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.32%
|
425,000
|
$4,458,000 | — | 30 Jun 2017 | |
| Redmile Group, LLC |
13F
|
Company |
0.33%
|
448,781
|
$4,237,000 | — | 30 Jun 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.27%
|
358,468
|
$3,761,000 | — | 30 Jun 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.27%
|
361,640
|
$3,637,000 | — | 30 Jun 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.25%
|
333,333
|
$3,497,000 | — | 30 Jun 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.23%
|
305,674
|
$3,042,000 | — | 30 Jun 2017 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.17%
|
223,972
|
$2,349,000 | — | 30 Jun 2017 | |
| Casdin Capital, LLC |
13F
|
Company |
0.16%
|
221,700
|
$2,326,000 | — | 30 Jun 2017 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.16%
|
217,841
|
$2,285,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.15%
|
205,800
|
$2,157,000 | — | 30 Jun 2017 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.1%
|
131,000
|
$1,374,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.07%
|
99,317
|
$1,042,000 | — | 30 Jun 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
87,943
|
$923,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
57,547
|
$604,000 | — | 30 Jun 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
49,600
|
$520,000 | — | 30 Jun 2017 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.03%
|
35,000
|
$367,000 | — | 30 Jun 2017 | |
| Lombard Odier Asset Management (USA) Corp |
13F
|
Company |
0.02%
|
31,250
|
$328,000 | — | 30 Jun 2017 | |
| NEXTHERA CAPITAL LP |
13F
|
Company |
0.02%
|
30,543
|
$320,000 | — | 30 Jun 2017 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
28,629
|
$301,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
27,842
|
$292,000 | — | 30 Jun 2017 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.02%
|
22,206
|
$233,000 | — | 30 Jun 2017 | |
| Laurion Capital Management LP |
13F
|
Company |
0.01%
|
20,000
|
$210,000 | — | 30 Jun 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
19,493
|
$204,000 | — | 30 Jun 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
18,443
|
$193,000 | — | 30 Jun 2017 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.01%
|
17,993
|
$189,000 | — | 30 Jun 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
14,500
|
$153,000 | — | 30 Jun 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.01%
|
13,561
|
$142,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
12,870
|
$135,000 | — | 30 Jun 2017 | |
| NORGES BANK |
13F
|
Company |
0.01%
|
12,155
|
$128,000 | — | 30 Jun 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
8,900
|
$93,000 | — | 30 Jun 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
7,900
|
$83,000 | — | 30 Jun 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0%
|
6,063
|
$64,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
5,057
|
$53,000 | — | 30 Jun 2017 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
3,132
|
$33,000 | — | 30 Jun 2017 | |
| Nationwide Fund Advisors |
13F
|
Company |
0%
|
2,879
|
$30,000 | — | 30 Jun 2017 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,500
|
$15,000 | — | 30 Jun 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,098
|
$11,000 | — | 30 Jun 2017 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
530
|
$5,560 | — | 30 Jun 2017 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
443
|
$5,000 | — | 30 Jun 2017 |
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q3 2017
As of 30 Sep 2017,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,221,932 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., JENNISON ASSOCIATES LLC, Redmile Group, LLC, OppenheimerFunds, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, SPHERA FUNDS MANAGEMENT LTD., AMERIPRISE FINANCIAL INC, and DRIEHAUS CAPITAL MANAGEMENT LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
43
Q3 2017 holders
42
Holder diff
-1
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.